1st Quarter - Report

BIOCOM for BIOCOM

Firm
Client
Income
—
Expenses
$52,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Voiced support for Medical Device Excise Tax Repeal Efforts.

LobbyistCovered position, as disclosed
MADELEINE BAUDOIN —
JOE PANETTA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Energy/Nuclear ENG

Voiced Support for the Energy Title programs within the 2002 and 2008 farm bills to be included in the Farm Bill.

LobbyistCovered position, as disclosed
MADELEINE BAUDOIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Voiced support for HR 2182, The Generativng Antibiotic Incentives Now ("GAIN") Act. The legislation provides incentives for the development of infectious disease products. Voiced opposition to HR 3699, the Research Works Act. Voiced support for HR 1862, the Regenerative Medicine Promotion Act. The legislation encourages private investment in R&D, and it enables accelerated approval for regenerative medicine products. Voiced opposition to HR 3433, the Grant Reform and New Transparency Act of 2011 (GRANT ACT). The legislation requires certain standards in the award of federal grants, and for other purposes. Voiced opposition over the IPAB. Voiced opposition over proposed cuts to Medicare Part D, which provides seniors with a drug benefit, and Part B, which provides onology products for administration in physicians offices.

LobbyistCovered position, as disclosed
MADELEINE BAUDOIN —
JOE PANETTA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3699 (112th), H.R. 2182 (112th), H.R. 1862 (112th), H.R. 3433 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.